Pacira Pharmaceuticals Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 0.59%

The Pacira Pharmaceuticals stock price gained 1.44% on the last trading day (Thursday, 2nd Jul 2026), rising from $25.03 to $25.39. During the last trading day the stock fluctuated 4.42% from a day low at $24.43 to a day high of $25.51. The price has risen in 7 of the last 10 days and is up by 12.15% over the past 2 weeks. Volume fell on the last day by -170 thousand shares and in total, 370 thousand shares were bought and sold for approximately $9.41 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $25.25 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $28.38 sometime during the next 3 months.

PCRX Signals & Forecast

Mostly positive signals in the chart today. The Pacira Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $24.92 and $23.40. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 14.11%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Pacira Pharmaceuticals stock

Pacira Pharmaceuticals finds support from accumulated volume at $25.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.08 between high and low, or 4.42%. For the last week, the stock has had daily average volatility of 4.59%.

Our recommended stop-loss: $24.16 (-4.84%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 21 days ago.)

Trading Expectations (PCRX) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Pacira Pharmaceuticals to open at $25.11, and during the day (based on 14 day Average True Range), to move between $24.92 and $25.86, which gives a possible trading interval of +/-$0.94 (+/-3.78%) up or down from last closing price. If Pacira Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 3.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $25.41 (0.08%) than the support at $25.24 (0.59%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pacira Pharmaceuticals stock A Buy?

Several short-term signals are positive and the stock has broken the horizontal trend up, which indicates an even stronger rate of rising. We conclude that the current level may hold a buying opportunity as there is a fair chance for Pacira Pharmaceuticals stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 2.485 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $25.11 ( 1.10%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk